Overexpression of Kinase-negative Protein Kinase Cdelta in Pancreatic Beta-cells Protects Mice from Diet-induced Glucose Intolerance and Beta-cell Dysfunction
Overview
Authors
Affiliations
Objective: In vitro models suggest that free fatty acid-induced apoptotic beta-cell death is mediated through protein kinase C (PKC)delta. To examine the role of PKCdelta signaling in vivo, transgenic mice overexpressing a kinase-negative PKCdelta (PKCdeltaKN) selectively in beta-cells were generated and analyzed for glucose homeostasis and beta-cell survival.
Research Design And Methods: Mice were fed a standard or high-fat diet (HFD). Blood glucose and insulin levels were determined after glucose loads. Islet size, cleaved caspase-3, and PKCdelta expression were estimated by immunohistochemistry. In isolated islet cells apoptosis was assessed with TUNEL/TO-PRO3 DNA staining and the mitochondrial potential by rhodamine-123 staining. Changes in phosphorylation and subcellular distribution of forkhead box class O1 (FOXO1) were analyzed by Western blotting and immunohistochemistry.
Results: PKCdeltaKN mice were protected from HFD-induced glucose intolerance. This was accompanied by increased insulin levels in vivo, by an increased islet size, and by a reduced staining of beta-cells for cleaved caspase-3 compared with wild-type littermates. In accordance, long-term treatment with palmitate increased apoptotic cell death of isolated islet cells from wild-type but not from PKCdeltaKN mice. PKCdeltaKN overexpression protected islet cells from palmitate-induced mitochondrial dysfunction and inhibited nuclear accumulation of FOXO1 in mouse islet and INS-1E cells. The inhibition of nuclear accumulation of FOXO1 by PKCdeltaKN was accompanied by an increased phosphorylation of FOXO1 at Ser256 and a significant reduction of FOXO1 protein.
Conclusions: Overexpression of PKCdeltaKN in beta-cells protects from HFD-induced beta-cell failure in vivo by a mechanism that involves inhibition of fatty acid-mediated apoptosis, inhibition of mitochondrial dysfunction, and inhibition of FOXO1 activation.
Upregulation of α-ENaC induces pancreatic β-cell dysfunction, ER stress, and SIRT2 degradation.
Zhang X, Zhang D, Huo L, Zhou X, Zhang J, Li M J Biomed Res. 2024; 38(3):241-255.
PMID: 38769731 PMC: 11144933. DOI: 10.7555/JBR.37.20230128.
Kowluru A Biochem Pharmacol. 2023; 218:115889.
PMID: 37991197 PMC: 10872519. DOI: 10.1016/j.bcp.2023.115889.
Hali M, Pinto N, Gleason N, Kowluru A Int J Mol Sci. 2023; 24(21).
PMID: 37958977 PMC: 10647342. DOI: 10.3390/ijms242115994.
Oquendo M, Lorza-Gil E, Juarez-Lopez D, Wagner R, Birkenfeld A, Ullrich S Sci Rep. 2022; 12(1):15831.
PMID: 36138030 PMC: 9499973. DOI: 10.1038/s41598-022-18262-0.
Protein Kinase C (Pkc)-δ Mediates Arginine-Induced Glucagon Secretion in Pancreatic α-Cells.
Honzawa N, Fujimoto K, Kobayashi M, Kohno D, Kikuchi O, Yokota-Hashimoto H Int J Mol Sci. 2022; 23(7).
PMID: 35409362 PMC: 8999522. DOI: 10.3390/ijms23074003.